Biomimetic Smart Aerosols for Lung Cancer, Tuberculosis & Other Pulmonary Diseases

Technology Description

Innovation is a platform technology for direct delivery of chemotherapy drug (paclitaxel) to the lungs using lung surfactant mimicking nanocarriers given as aerosols via inhalation. These smart carriers release the drug at the site where tumor specific pH is encountered. This technology provides the benefits of non-invasive needle-free delivery, ease of administration, reduced costs, tumor specificity, high efficacy and low systemic toxicity as compared to conventional intravenous chemotherapy injections. Further, this innovation is a platform technology which is thoroughly evaluated for paclitaxel delivery to treat lung cancer but can also be used to treat other lung disorders like tuberculosis, pneumonia, asthma, chronic obstructive pulmonary disorder.

For further information please contact

Information Manager
Email: timeis@ficci.com